Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Banner image

IP LitigationLife Sciences

Biosimilars 2017 Year in Review

February 9, 2018

IP LitigationLife Sciences

Biosimilars 2017 Year in Review

February 9, 2018

Back to Fish's Litigation Blog

 

Since the passage of the Biologics Price Competition and Innovation Act (BPCIA), 2017 has been the most active year yet for drug manufacturers. Fish attorneys Tasha Francis, Jenny Shmuel, and Brianna Chamberlin addressed the guidance and changes of 2017 in a recent article titled “Biosimilars 2017 Year in Review” featured in the Bloomberg Law Pharmaceutical Law & Industry Report®.

The article reviews the guidance from the Supreme Court and the Federal Circuit on the bounds of the BPCIA and discusses the greatly anticipated FDA draft guidance on biosimilar interchangeability.

On February 7, 2018, the head of Fish’s regulatory practice, Terry Mahn, testified in front of the U.S. Senate Special Committee on Aging and referenced this article as a resource for more information. Video of this testimony can be found here.

Click here to read the full article.

Related Tags

BPCIA
biosimilars

Blog Authors

Headshot
Brianna Chamberlin | Associate

Brianna Chamberlin is a litigation associate in Fish & Richardson’s Twin Cities office. Ms. Chamberlin was previously a Summer Associate with Fish, in which she collaborated to advise clients on obviousness-type double patenting and terminal disclaimers. She also aided in deposition preparation, drafted memoranda on substantive patent law...

Headshot
Jenny Shmuel, Ph.D. | Associate

  Dr. Jenny Shmuel represents clients on a range of intellectual property matters, with an emphasis on medical device and pharmaceutical technologies. She has extensive experience in pre-suit diligence, case management, expert and fact discovery, and brief writing, and...

Headshot
Tasha M. Francis, Ph.D. | Associate

Tasha Francis, Ph.D., an associate in Fish & Richardson’s Twin Cities office, practices intellectual property litigation with an emphasis on patent litigation. Dr. Francis has represented plaintiffs and defendants in cases involving medical devices, biotechnology, and...

Leave a Reply

Your email address will not be published. Required fields are marked *